US3022308A - Decahydrobenzopyridine quaternaries - Google Patents

Decahydrobenzopyridine quaternaries Download PDF

Info

Publication number
US3022308A
US3022308A US700280A US70028057A US3022308A US 3022308 A US3022308 A US 3022308A US 700280 A US700280 A US 700280A US 70028057 A US70028057 A US 70028057A US 3022308 A US3022308 A US 3022308A
Authority
US
United States
Prior art keywords
quaternary ammonium
dibromide
cis
reacted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US700280A
Inventor
Cavallito Chester John
Gray Allan Poe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Irwin Neisler and Co
Original Assignee
Irwin Neisler and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irwin Neisler and Co filed Critical Irwin Neisler and Co
Priority to US700280A priority Critical patent/US3022308A/en
Application granted granted Critical
Publication of US3022308A publication Critical patent/US3022308A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/037—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements with quaternary ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/10—Quaternary compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Definitions

  • This invention relates to unsymmetrical bis-(quaternary ammonium)-subs tituted alkane salts, and is more particularly concerned with such compounds wherein the two quaternary ammonium nitrogens are separated by 2 to 4 carbon atoms, inclusive, of the alkane portion of the molecule, wherein the smaller quaternary ammonium group contains up to six carbon atoms and up to one-N- heteromonocyclic group, and wherein the larger quaternary ammonium group is a N-lower-alkyldecahydrobenzopyridinium radical. It is the concept of a composition of matter having a molecular structure wherein this particular larger quaternary ammonium group is separated by 2-4 carbons from the smaller quaternary ammonium group that is the specific inventive feature.
  • N lower-alkyldecahydrobenzopyridinium radical includes N lower-alkyldecahydroquinolinium and N- lower-alkyldecahydroisoquinolinium structures wherein the lower-alkyl substituent contains up to about four carbons.
  • the smaller quaternary ammonium radical includes trimethylammonium, N-methylpiperidinium, N-methylmorpholinium, N methylpyrrolidinium, dimethylethylampremium and diethylmethylammonium with trimethylammonium and N-methylpyrrolidinium as preferred structures.
  • the two quaternary ammonium nitrogens may be' separated by 2-4 carbon atoms of the alkane, with separa tion by 2 or 3 carbons being preferred.
  • the alkane chain can be branched chain or straight chain and can contain up to about six carbon atoms.
  • the quaternary ammonium nitrogens may be attached at the ends of the alkane chain or in any portion therein so long as they nary ammonium group contains up to 6 carbon atoms,
  • the compounds of the present invention are generally solids, which can exist in the cis or trans form or as mixtures thereof and any and all forms of the compound are intended when not otherwise specified.
  • the isomerism is in the juncture of the two rings of the decahydrobenzopyridine system.
  • Those compounds which contain "the decahydroquinolinium structure are generall-ymore dioxane-alcohol mixtures, et cetera.
  • olines react more rapidly than do the corcutaneously, and intracutaneously in solid form as in a tablet or in liquid form in water or with any ofthe usual excipients.
  • the compounds of the present invention can be made by the reaction of a suitable haloalkyl quaternary ammonium halide (that which corresponds to all of the desired end molecule save the larger quaternary ammonium moiety) with the appropriate N-lower-alklydecahydrobenzopyridine-
  • a suitable solvent' such as acetonitrile, dimethylformamide, alcohol,
  • Another method of preparingthe compounds of the present invention which sometimes may be used is to bisquaternize the free diamine base corresponding to the desired end molecule.
  • Example 1 An acetonitrile solution of 5.4 grams (0.035 mole) of .1-methyldecahydroquinoline (cis-trans mixture) and 9.1 grams (0.035 mole) of 3-bromopropyltrimethylammonium bromide was refluxed on the steamhath for 15 hours. The cooled solution was diluted with ether to yield 12.8 grams (88 percent of theory) of trimethylene-l-(l-methyldecahydroquinolinium)-3 (trimethylammonium) dibromide as a hygroscopic solid, melting with gas evolution at 108-110 degrees ccntigrade.
  • Example 2 A-s'olution of 8:0gr'ams (0.05 mole) of Lmethyl-transdecahydroquinoline and 13.6 grams (0.05 mole) of 3- brornopropyltrimethyl-ammonium bromide in isopropyl alcohol was refluxed on the steam-bath for 24 hours. Addition of ether to the cooled solution precipitated an oil which was'diss'olved in ethanol and reprecipitated with ether.
  • Example 3 Following the procedure of Example 2, l-ethyldecahydroquinoline (from -a mixture of cis and trans-decahydroquinoline) was reacted with 3-bromopropyltrimethylammonium bromide to yield 65 percent of the theoretical of trimethy lene-1-( 1-ethyldecahydroquinolinium) -3-(trimethylammonium) dibromide, an extremely hygroscopic material. It is'probable that the product is almost en Analysis.-Calculated: Br, 37.32. Found: Br, 37.23. tirely derived from cis-decahydroquinoline.
  • Example 4 Essentially as described in Example 1, reaction of 1- methyl-trans-decahydroquinoline with 3-bromopropyl-N- methylpyrrolidinium bromide afiorded 52 percent of the theoretical yield of trimethylene- 1-( l-methyl-tr'ans-decahydroquinoliniu'm) -3-( l methylpyrrolidinium) dibromide as a hygroscopic solid melting at 87-88 degrees centi- "grade.
  • Example 5 To 30 grams (0.22'mole) of decahydroquinoline (c-is-trans mixture) was added, dropwise with stirring, a solution of 11.”6 grams (0.11 mole) of dimethylaminoethyl chloride in 75 milliliters of benzene. The reaction mixture was refluxed on the steam-bath for 80 hours. Filtering off the precipitate of decahydroquinoline hydrochloride and distilling the residue yielded 9.0 grams (40 percent of theory) of 1-(dimethylaminoethyl)-decahyd'roquinoline, boiling'point 104106 degrees centigrade at 1.5 millimeters, r1 1.4862.
  • Example 6 Following the general procedure described in Example 6, Z-methyldecahydroisoquinoline was reacted with 3- bromopropyl-l-methylpyrrolidinium bromide to afiord colorless crystals of trimethylene-l-(Z-methyldecahydroisoquinolinium) 3 (l-methylpyrrolidinium) dibromide,
  • Example 8 Following the procedure of Example 1, l-butyldecahydroquinoline (cis-trans mixture) was reacted with 4- chlorobutyltrimethyl-ammonium chloride to produce tet- "ramethylehe-l-(1-burtyldeoahydroquinolinium) 4 (trimethylamrnonium) dichloride as a hygroscopic solid.
  • Example 9 Following the procedure of Example 2, l-ethyl-transdecahydroquinoline was reacted with 3-iodopropyldiethylmethylamrnonium iodide to produce trimethylene-l-(lethyl-trams-decahydroquinolinium) 3-(diethylmethylammoniurn) diiodide as an extremely hygroscopic solid.
  • Example 10 Example 1 1 Following the'procedure of Example 7, Z-methyldecahydroisoquinoline was reacted with '4-chlo'rohutyltri- 'methylammonium chloride to produce tetramethylene-l- (2-methyldecahydroisoquinolinium) 4 (trimethylammoniu m) dichloride.
  • Example 12 Following the procedure of Example 3, 2-ethyldecahydroisoquinoline was reacted with 3-bromopropyltrimethylammonium bromide to produce trimethylene-1-(2-ethyldecahydroisoquinolinium)-3 (trirnethylarnmonium) dih'romide.
  • Example 13 7 Following the procedure of Example 7, 2-ethyldecahy- E a droisoquinoline was reacted with 2-br'omoethylriiethylpyrrolidinium bromide to produce ethylene-1-2(-ethyldecahydroisoquinolinium 2 (methylpyrrolidinium) dibromide.
  • Example 14 Following the procedure of Example 7, 2-butyldecahydroisoquinoline was reacted with B-bromopropyl-N-methylmorpholinium bromide to produce trimethylene-l- (2 butyldecahydroisoquinolinium) 3 (methylmorphm linium) dibromide.
  • Example 15 Essentially as described in our paper J. Am. Chem. Soc., 77, 3648 (1955), trimethylamine was reacted with l-bromo-2-bromornethylbutane to provide Z-bromomethylbutyltrimethylammonium bromide. Then, following the procedure of Example 1, this was reacted with 1methyldecahydroquinoline (cis-trans mixture) to yield Z-ethyltrimethylene-1 (1 methyldecahydroquinolinium) 3 (trimethyl-ammonium) dibromide.
  • Example 16 In a similar manner to Example 15, N-methylpyrrolidine was reacted with 2,4-dibromopentane to provide 1-(4-bromo-2 pentyl) l methylpyrrolidinium bromide. Then, following the procedure of Example 7, this was reacted with 2-methyldecahydroisoquinoline to yield 1,3-dimethyltrimethylene-l (Z-methyldecahydroisoquin linium)-3-(l-methylpyrrolidinium) dibromide.
  • Example 17 In a similar manner to Example 15, trimethylamine was reacted with 1,4-dibromo-2-methylpehtane to provide 4-bromo-2-methyl-l-pentyltrimethylammonium 'bromide. Then, following the procedure of Example 6, this was reacted with Z-methyldecahydroisoquinoline to yield 1,3- -dimethyltetramethylene 1 (Z-methyldecahydroisoquinm linium)-4-(trimethylammonium) dibromide.
  • Example 18 Two equivalents of decahydroquinoliue (cis-trans mixture) was reacted with 1 equivalent of 1,3-dichloro butane in benzene solution, in a manner similar to that described in Example A, to provide 1-(3-chlorobutyl)- cis-decahydroquinoline. This, reacted with pyrrolidine in essentially the same manner, yielded l-(3-pyrrolidino butyl)-cis-decahydroquinoline, which was then treated with excess methyl iodide to yield l-methyltrimethylene- 3 l methyl-cis-decahydroquinolinium) 1 (l-methylpyrrolidinium) diiodide.
  • Example 4 Effect when the compound of Example 4 was administered intravenously to an unaesthetized male monkey in a dosage of 0.75 milligrams per kilogram of body weight was: No immediate etfects. The animal became somewhat quieter and there was possibly some dilation of the pupils. The monkey showed no evidence of dry mouth or postural hypotension.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

No Drawing.
3 022 308 DECAHYDROBENZOI WRIDINE QUATERNARIES Chester John Cavallito and Allan Poe Gray, Decatur,
111., assignors to Irwin, Neisler and Co., Decatur, Ill,
a corporation of Illinois Filed Dec. 3, 1957, Ser. No. 700,280 7 Claims. (Cl. 260286) This invention relates to unsymmetrical bis-(quaternary ammonium)-subs tituted alkane salts, and is more particularly concerned with such compounds wherein the two quaternary ammonium nitrogens are separated by 2 to 4 carbon atoms, inclusive, of the alkane portion of the molecule, wherein the smaller quaternary ammonium group contains up to six carbon atoms and up to one-N- heteromonocyclic group, and wherein the larger quaternary ammonium group is a N-lower-alkyldecahydrobenzopyridinium radical. It is the concept of a composition of matter having a molecular structure wherein this particular larger quaternary ammonium group is separated by 2-4 carbons from the smaller quaternary ammonium group that is the specific inventive feature.
3,022,308 Patented Feb. 20, 1962 i ly ic hygroscopic than those containing the decahydroisoquinolinium group.
The compounds of the present invention have been evaluated by standard pharmacological testing procedures and demonstrated to produce hypotensive activity in living animals. This hypotensive activity is not related to the peripheral ganglionic blocking activity of the compounds and, as a result, this provides the advantage of eliminating many of the undesirable side reactions associated with mal organism orally, intravenously, intramuscularly, sub- The, N lower-alkyldecahydrobenzopyridinium radical includes N lower-alkyldecahydroquinolinium and N- lower-alkyldecahydroisoquinolinium structures wherein the lower-alkyl substituent contains up to about four carbons. j
The smaller quaternary ammonium radical includes trimethylammonium, N-methylpiperidinium, N-methylmorpholinium, N methylpyrrolidinium, dimethylethylampremium and diethylmethylammonium with trimethylammonium and N-methylpyrrolidinium as preferred structures.
The two quaternary ammonium nitrogens may be' separated by 2-4 carbon atoms of the alkane, with separa tion by 2 or 3 carbons being preferred. The alkane chain can be branched chain or straight chain and can contain up to about six carbon atoms.
The quaternary ammonium nitrogens may be attached at the ends of the alkane chain or in any portion therein so long as they nary ammonium group contains up to 6 carbon atoms,
inclusive, and up to one N-teteromonocyclic group; wherein the other quaternary ammonium group is a N-loweralkyldecahydrobenzopyridine radical and, wherein the anions are non-toxic acid residues.
The compounds of the present invention are generally solids, which can exist in the cis or trans form or as mixtures thereof and any and all forms of the compound are intended when not otherwise specified. The isomerism is in the juncture of the two rings of the decahydrobenzopyridine system. Those compounds which contain "the decahydroquinolinium structure are generall-ymore dioxane-alcohol mixtures, et cetera.
J hydrobenzopyridine nucleus.
olines (for example) react more rapidly than do the corcutaneously, and intracutaneously in solid form as in a tablet or in liquid form in water or with any ofthe usual excipients. I i
The compounds of the present invention can be made by the reaction of a suitable haloalkyl quaternary ammonium halide (that which corresponds to all of the desired end molecule save the larger quaternary ammonium moiety) with the appropriate N-lower-alklydecahydrobenzopyridine- The reaction is carried out ina suitable solvent'such as acetonitrile, dimethylformamide, alcohol,
Reaction 'is preferably carried out at reflux temperatures over prolonged time periods /24 days). Some of the starting omegahaloalkyl quaternary ammonium halides are reported in J.A.( 3.S. -77, 3648 (1955) and a type process whereby such class of intermediates can be prepared, for their preparation is described in our copending application Serial 406,053 filed January 25, 1954; which issued December 24, 1957 asU.S. Patent 2,817,664.
The use of a cis or a trans-decahydrobenzopyridine starting base will yield a bis-quaternary ammonium salt product with, respectively, a cisor a trans-fused deca- N-alkyl-cis-decahydroquinresponding trans-isomers, but if the quaternization of a cis-trans mixture of isomeric decahydroquinolines is carried essentially to completion the product will likewise be a mixture of isomers. If, however, two equivalents of a cis-trans mixture of the secondary decahydroquinoline bases are alkylated with one equivalent of an alkyl halide, there is' obtained one equivalent each of transdecahydroquinoline hydrohalide and of an N-alkyl-cisdecahydroquinoline. The latter will then yield a bisquaternary ammonium salt product with a cis-fused decahydroquinoline nucleus. V I
Another method of preparingthe compounds of the present invention which sometimes may be used is to bisquaternize the free diamine base corresponding to the desired end molecule.
The following examples will more particularly illustrate the compounds of the present invention and the procedures whereby they may be prepared, but are not to be construed aslimiting.
. I Example 1 An acetonitrile solution of 5.4 grams (0.035 mole) of .1-methyldecahydroquinoline (cis-trans mixture) and 9.1 grams (0.035 mole) of 3-bromopropyltrimethylammonium bromide was refluxed on the steamhath for 15 hours. The cooled solution was diluted with ether to yield 12.8 grams (88 percent of theory) of trimethylene-l-(l-methyldecahydroquinolinium)-3 (trimethylammonium) dibromide as a hygroscopic solid, melting with gas evolution at 108-110 degrees ccntigrade.
Analysis.-Calculated: C, 46.38; H, 8.29; Br, 38.58. Found: C, 46.11; H, 8.10; Br, 38.15.
Example 2 A-s'olution of 8:0gr'ams (0.05 mole) of Lmethyl-transdecahydroquinoline and 13.6 grams (0.05 mole) of 3- brornopropyltrimethyl-ammonium bromide in isopropyl alcohol was refluxed on the steam-bath for 24 hours. Addition of ether to the cooled solution precipitated an oil which was'diss'olved in ethanol and reprecipitated with ether. Drying the oil over P in vacuo afforded 11.0 grams (51 percent of the theoretical yield) of trimethylene-1-( l-methyl-tran's decahydr'oquinolinium)-3 (trimethylarnmonium) dibrornide as an extremely hygroscopic solid, melting from 130 to 136 degrees centigrade.
Analysis- Calculated: C, 46.38; H, 8.29; Br, 38.58.
Found: c, 45.56; H, 3.27; Br, 38.33.
Example 3 Following the procedure of Example 2, l-ethyldecahydroquinoline (from -a mixture of cis and trans-decahydroquinoline) was reacted with 3-bromopropyltrimethylammonium bromide to yield 65 percent of the theoretical of trimethy lene-1-( 1-ethyldecahydroquinolinium) -3-(trimethylammonium) dibromide, an extremely hygroscopic material. It is'probable that the product is almost en Analysis.-Calculated: Br, 37.32. Found: Br, 37.23. tirely derived from cis-decahydroquinoline.
Example 4 Essentially as described in Example 1, reaction of 1- methyl-trans-decahydroquinoline with 3-bromopropyl-N- methylpyrrolidinium bromide afiorded 52 percent of the theoretical yield of trimethylene- 1-( l-methyl-tr'ans-decahydroquinoliniu'm) -3-( l methylpyrrolidinium) dibromide as a hygroscopic solid melting at 87-88 degrees centi- "grade.
Afialysis.- Calculated: c, 49.09; H, 3.24; Br, 36.30. Found: 0, 43.50; a, 8.08; Br, 3572.
Example 5 A. To 30 grams (0.22'mole) of decahydroquinoline (c-is-trans mixture) was added, dropwise with stirring, a solution of 11."6 grams (0.11 mole) of dimethylaminoethyl chloride in 75 milliliters of benzene. The reaction mixture was refluxed on the steam-bath for 80 hours. Filtering off the precipitate of decahydroquinoline hydrochloride and distilling the residue yielded 9.0 grams (40 percent of theory) of 1-(dimethylaminoethyl)-decahyd'roquinoline, boiling'point 104106 degrees centigrade at 1.5 millimeters, r1 1.4862. Since the decahydroquinolinehyd'rochloride obtained wasshown to be almost pure trans '(melting'point of the base), it is probable that "the product "is essentially derived from cis-decahydroquin anol-ethyl acetate, yielding 9 grams ('72 percent of theory) of ethylene 1 (1-methyldecahydroquinolinium)-2-(trimethylammonium) dibromide as a hygroscopic solid, melting at 142 degrees centigrade With decomposition.
Analysis-Calculated: C, 45.00; H, 8.06; Br, 39.93. Found: C, 44.75; H, 7.78; Br, 39.91.
Example 6 Example 7 Following the general procedure described in Example 6, Z-methyldecahydroisoquinoline was reacted with 3- bromopropyl-l-methylpyrrolidinium bromide to afiord colorless crystals of trimethylene-l-(Z-methyldecahydroisoquinolinium) 3 (l-methylpyrrolidinium) dibromide,
melting point 218-220 degrees centigrade, after several recrystallizations from isopropyl alcohol. 7
Analysis----Calculated: C, 49.09; H, 8.24; Br, 36.30. Found: C, 49.45; H, 8.64; Br, 36.22.
From the isopropyl alcohol mother liquors there was obtained a smaller amount of crystalline material, which melted at 196-499 degrees centigrade after recrystallization from isopropyl alcohol and was apparently "a stereoisomeric trimethylene-1-(2-methyldec ahydroisoquinolinium) -3-( l-methylpyrrolidinium) dibromide.
Analysis.Calculated: C, 49.09; H, 8.24; Br, 36.30. Found: C, 49.32; H, 8.2.9; Br, 36.48.
Example 8 Following the procedure of Example 1, l-butyldecahydroquinoline (cis-trans mixture) was reacted with 4- chlorobutyltrimethyl-ammonium chloride to produce tet- "ramethylehe-l-(1-burtyldeoahydroquinolinium) 4 (trimethylamrnonium) dichloride as a hygroscopic solid.
Example 9 Following the procedure of Example 2, l-ethyl-transdecahydroquinoline was reacted with 3-iodopropyldiethylmethylamrnonium iodide to produce trimethylene-l-(lethyl-trams-decahydroquinolinium) 3-(diethylmethylammoniurn) diiodide as an extremely hygroscopic solid.
Example 10 Example 1 1 Following the'procedure of Example 7, Z-methyldecahydroisoquinoline was reacted with '4-chlo'rohutyltri- 'methylammonium chloride to produce tetramethylene-l- (2-methyldecahydroisoquinolinium) 4 (trimethylammoniu m) dichloride.
"Example 12 Following the procedure of Example 3, 2-ethyldecahydroisoquinoline was reacted with 3-bromopropyltrimethylammonium bromide to produce trimethylene-1-(2-ethyldecahydroisoquinolinium)-3 (trirnethylarnmonium) dih'romide.
. Example 13 7 Following the procedure of Example 7, 2-ethyldecahy- E a droisoquinoline was reacted with 2-br'omoethylriiethylpyrrolidinium bromide to produce ethylene-1-2(-ethyldecahydroisoquinolinium 2 (methylpyrrolidinium) dibromide.
Example 14 Following the procedure of Example 7, 2-butyldecahydroisoquinoline was reacted with B-bromopropyl-N-methylmorpholinium bromide to produce trimethylene-l- (2 butyldecahydroisoquinolinium) 3 (methylmorphm linium) dibromide.
Example 15 Essentially as described in our paper J. Am. Chem. Soc., 77, 3648 (1955), trimethylamine was reacted with l-bromo-2-bromornethylbutane to provide Z-bromomethylbutyltrimethylammonium bromide. Then, following the procedure of Example 1, this was reacted with 1methyldecahydroquinoline (cis-trans mixture) to yield Z-ethyltrimethylene-1 (1 methyldecahydroquinolinium) 3 (trimethyl-ammonium) dibromide.
Example 16 In a similar manner to Example 15, N-methylpyrrolidine was reacted with 2,4-dibromopentane to provide 1-(4-bromo-2 pentyl) l methylpyrrolidinium bromide. Then, following the procedure of Example 7, this was reacted with 2-methyldecahydroisoquinoline to yield 1,3-dimethyltrimethylene-l (Z-methyldecahydroisoquin linium)-3-(l-methylpyrrolidinium) dibromide.
Example 17 In a similar manner to Example 15, trimethylamine was reacted with 1,4-dibromo-2-methylpehtane to provide 4-bromo-2-methyl-l-pentyltrimethylammonium 'bromide. Then, following the procedure of Example 6, this was reacted with Z-methyldecahydroisoquinoline to yield 1,3- -dimethyltetramethylene 1 (Z-methyldecahydroisoquinm linium)-4-(trimethylammonium) dibromide.
Example 18 Two equivalents of decahydroquinoliue (cis-trans mixture) was reacted with 1 equivalent of 1,3-dichloro butane in benzene solution, in a manner similar to that described in Example A, to provide 1-(3-chlorobutyl)- cis-decahydroquinoline. This, reacted with pyrrolidine in essentially the same manner, yielded l-(3-pyrrolidino butyl)-cis-decahydroquinoline, which was then treated with excess methyl iodide to yield l-methyltrimethylene- 3 l methyl-cis-decahydroquinolinium) 1 (l-methylpyrrolidinium) diiodide.
Example 19 I. Acute toxicity (LD by intravenous injection in mice-dosage in terms of milligrams per kilogram of body weight:
Compound of Example: I.V. toxicity 1 67.5
4 63.0 5 31.5 7 (high melting) 60.5
7 (low melting) 62.0
II. Hypo'tensive activity: Effects on the blood pressure of anesthetized dogs:
Compound of Example LV. dose, Percent Duration mgjkg. 13.1. fall hours 0.025 20 0.6 0.05 35 2 0.1 3 7 (high-melting material) 0.01 0. 025 5 0.05 45 2 0.1 65-70 3 7 (low melting material) 0. 5 40 3 0.1 55-60 3 III. Sympathetic ganglionic blockade on anesthetized cats by superior cervical ganglion-nictitating membrane preparation-electrical stimulation:
Compound of LV. dose, Degree of block (04-|- Duration,
Example mgJkg. where 4+ is complete hours blockade) IV. Effect on the pupils of unanesthetized male cats:
V. Effect when the compound of Example 4 was administered intravenously to an unaesthetized male monkey in a dosage of 0.75 milligrams per kilogram of body weight was: No immediate etfects. The animal became somewhat quieter and there was possibly some dilation of the pupils. The monkey showed no evidence of dry mouth or postural hypotension.
Various modifications which will be obvious to those skilled in the art may be made in the present invention without departing from the spirit or scope thereof, and it is to be understood that we intend to limit ourselves only by the scope of the appended claims.
We claim:
1. Bis (quaternary ammonium) substituted alkane salts; wherein the alkane portion is selected from the group consisting of alkanes having 2-6 carbon atoms; wherein one quaternary ammonium group is selected from the group consisting of trimethylammonium, dimethylethylarnmonium, diethylmethylammonium, N- methylpiperidinium, N-methylmorpholinium and N- methylpyrrolidinium; wherein the other quaternary ammonium group is N-lower-alkyldecahydrobenzopyridinium; wherein the two quaternary nitrogen atoms are separated by from 2 to 4 carbon atoms, inclusive, of the alkane poytion of the, molecule; and wherein the two anions are each non-toxic acid residues.
2. Trimethylene- 1 (1 methyidecahydroquinohnium)-3-(trimethylammonium) dihromide.
3. Trimethylene 1 (1 methyl trans decahydi'oquinoliniun1)3 trimethy] ammonium) dibromide.
4.. Trimethylene 1 (1 methy1- trans decahydroquinoliniurn) -3-( 1-methy1pyn'olidinium) dibromide.
5. Ethylene 1 (1 methyldec'ahydroquinolinum) 2- (trimethylammcnium) dibromidc.
6. Trimethylene 1 (2 methyldecahydroisoquinolinium)-3-(trimethyiamrnoniurn) dibromide.
7. Trirn ethylene 1 (2 methyldeeahyroisoquino 1inium)-3-(1-n1ethy1pyrro1ic1inium) dibromide.
References Cited in the file of this patent UNITED STATES PATENTS OTHER REFERENCES Rice: J.A C.S., vol. 75 (page 4911) (1953). Gray et' 31.: J.A.C.S., v01. 77 (1955) p. 3536.

Claims (2)

1. BIS - (QUATERNARY AMMONIUM) - SUBSTITUTED ALKANE SALTS; WHEREIN THE ALKANE PORTION IS SELECTED FROM THE GROUP CONSISTING OF ALKANES HAVING 2-6 CARBON ATOMS; WHREIN ONE QUATERNARY AMMONIUM GROUP IS SELECTED FORM THE GROUP CONSISTING OF TRIMETHYLAMMONIUM, DIMETHYLETHYLAMMONIUM DIETHYLMETHYLAMMONIUM, NMETHYLPIPERIDINIUM, N-METHYLMORPHOLINIUM AND NMETHYLPYRROLIDINIUM; WHEREIN THE OTHER QUATERNARY AMMONIUM GROUP IS N-LOWER-ALKYLDECAHYDROBENZOPYRIDINIUM; WHEREIN THE TWO QUATERNARY NITROGEN ATOMS ARE SEPATED BY FROM 2 TO 4 CARBON ATOMS, INCLUSIVE, OF THE ALKANE PORTIONS OF THE MOLECULE; AND WHEREIN THE TWO ANIONS ARE EACH NON-TOXIC ACID RESIDUES.
2. TRIMETHYLENE - 1 - (1 - METHYLDECAHYDROQUINOLINIUM)-3-(TRIMETHYLAMMONIUM) DIBROMIDE.
US700280A 1957-12-03 1957-12-03 Decahydrobenzopyridine quaternaries Expired - Lifetime US3022308A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US700280A US3022308A (en) 1957-12-03 1957-12-03 Decahydrobenzopyridine quaternaries

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US700280A US3022308A (en) 1957-12-03 1957-12-03 Decahydrobenzopyridine quaternaries

Publications (1)

Publication Number Publication Date
US3022308A true US3022308A (en) 1962-02-20

Family

ID=24812909

Family Applications (1)

Application Number Title Priority Date Filing Date
US700280A Expired - Lifetime US3022308A (en) 1957-12-03 1957-12-03 Decahydrobenzopyridine quaternaries

Country Status (1)

Country Link
US (1) US3022308A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379730A (en) * 1965-07-16 1968-04-23 Marion Laboratories Inc Production of 5, 6, 7 or 8-hydroxy-1, 2, 3, 4-tetrahydro and decahydro-isoquinolines
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
WO1999052857A1 (en) * 1998-04-14 1999-10-21 Smithkline Beecham Plc Novel compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1108117A (en) * 1953-02-11 1956-01-09 Iso-indols and their preparation process
US2834779A (en) * 1956-12-11 1958-05-13 Lakeside Lab Inc Disubstituted aminoalkyl quinuclidinium derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1108117A (en) * 1953-02-11 1956-01-09 Iso-indols and their preparation process
US2834779A (en) * 1956-12-11 1958-05-13 Lakeside Lab Inc Disubstituted aminoalkyl quinuclidinium derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3379730A (en) * 1965-07-16 1968-04-23 Marion Laboratories Inc Production of 5, 6, 7 or 8-hydroxy-1, 2, 3, 4-tetrahydro and decahydro-isoquinolines
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
WO1999052857A1 (en) * 1998-04-14 1999-10-21 Smithkline Beecham Plc Novel compounds

Similar Documents

Publication Publication Date Title
US3341584A (en) Anilides
US3723524A (en) Polar-substituted propanolamines as anti-angina and anti-hypertensive agents
US4241060A (en) Nitroimidazoles and compositions thereof
US3639476A (en) Substituted 1-dimethylamino pentanes and heptanes
US3660423A (en) 2-(substituted benzyl)methyl-2-imidazolines
US3494920A (en) 1-di(lower)alkylamino(lower)alkyl-3-(2-substituted ethyl) indoles
US3055939A (en) Unsymmetric bis-ammonium salts
US4018830A (en) Phenylthioaralkylamines
US3432600A (en) Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline
US3637852A (en) 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
US2695295A (en) Unsymmetrical n, n'-substituted ethylenediamine and piperazine compounds
US3022308A (en) Decahydrobenzopyridine quaternaries
US3772308A (en) Cyclopentanecetamides and cyclopentaneacetonitriles
US4055665A (en) Treating arrythmia with phenylthioaralkylamines
IL43079A (en) 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them
US2886572A (en) Z-aminobenzoxazoles
Leonard et al. 2-thenyl substituted diamines with antihistaminic activity
US3674787A (en) 2-(alpha-morpholinobenzyl)-anilides
Faust et al. Antihypertensive Agents: Derivatives of 2-Imidazoline and 1, 4, 5, 6-Tetrahydropyrimidine1a
US3544587A (en) Substituted toluidides and compositions containing them
US3988371A (en) Meta-[2-(benzylamino)-ethyl] benzoic acid amides
US3539642A (en) 2-phenyl-2-(1-naphthyl)acetamides
US3163649A (en) Substituteb phenyl-piperazine
US3423424A (en) 3-phenyl-4-dialkylaminoalkyl-pyrazol-5-ol compounds
US2714613A (en) Di-(p-substituted phenyl)-thioureas